Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Cheap, Paper-Based Testing Platform Could Transform Diagnostics

By LabMedica International staff writers
Posted on 16 Oct 2024

At-home diagnostic tests, such as pregnancy or COVID tests, utilize paper-based assay technology to identify the presence of target molecules. More...

Although these tests are simple and inexpensive, they primarily provide qualitative results, indicating whether a biomarker is present. In contrast, field-effect transistors (FETs), which were initially created for electronic devices, are capable of detecting the concentrations of biological molecules. Today, they serve as highly sensitive biosensors for real-time biomarker detection. Many experts believe that FETs represent the future of biosensing; however, their commercialization has been limited due to the specific testing conditions required. In a highly complex matrix like blood, FETs often struggle to detect signals from analytes. Researchers have now developed a new diagnostic test system that merges an FET with a cost-effective, paper-based diagnostic test. When paired with machine learning, this system evolves into a novel biosensor that could potentially revolutionize at-home testing and diagnostics.

Developed jointly by researchers at the University of Chicago Pritzker School of Molecular Engineering (PME, Chicago, Il, USA) and UCLA Samueli School of Engineering (Los Angeles, CA, USA), the new kind of testing system integrates an FET with a paper-based analytical cartridge, similar to the technology used in at-home pregnancy and COVID tests. This combination harnesses the high sensitivity of FETs along with the low-cost benefits of paper-based cartridges. The paper fluidic technology, particularly its porous sensing membrane, reduces the need for the complicated, controlled testing environments that FETs typically require. Additionally, it offers a low-cost basis for the system, as each cartridge costs approximately 15 cents.

The integration of deep-learning kinetic analysis further enhances the accuracy and precision of the testing results within the FET. To evaluate the system, the researchers programmed the device to measure cholesterol levels from anonymized, leftover human plasma samples. The study results published in ACS Nano indicate that across 30 blind tests, the system measured cholesterol levels with over 97% accuracy—well above the total allowable error of 10% stipulated by CLIA guidelines. The team also conducted a proof-of-concept experiment demonstrating that the device could accommodate immunoassays, which are widely used to quantify hormones, tumor markers, and cardiac biomarkers. The next steps involve developing the system for immunoassay testing, with the ultimate goal of showcasing its ability to detect multiple biomarkers from a single sample input.

“By addressing the limitations in each component and adding in machine learning, we have created a new testing platform that could diagnose disease, detect biomarkers, and monitor therapies at home,” said Hyun-June Jang, a postdoctoral fellow and co-lead author on the paper. “This technology has the potential to detect multiple biomarkers from a single drop of blood.”


New
Gold Member
Automatic Chemiluminescence Immunoassay Analyzer
Shine i2000
Collection and Transport System
PurSafe Plus®
Alcohol Testing Device
Dräger Alcotest 7000
ESR Analyzer
TEST1 2.0
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more

Immunology

view channel
Image: The CloneSeq-SV approach can allow researchers to study how cells within high-grade serous ovarian cancer change over time (Photo courtesy of MSK)

Blood Test Tracks Treatment Resistance in High-Grade Serous Ovarian Cancer

High-grade serous ovarian cancer (HGSOC) is often diagnosed at an advanced stage because it spreads microscopically throughout the abdomen, and although initial surgery and chemotherapy can work, most... Read more

Industry

view channel
Image: The collaboration aims to improve access to Hb variant testing with the Gazelle POC diagnostic platform (Photo courtesy of Hemex Health)

Terumo BCT and Hemex Health Collaborate to Improve Access to Testing for Hemoglobin Disorders

Millions of people worldwide living with sickle cell disease and other hemoglobin disorders experience delayed diagnosis and limited access to effective care, particularly in regions where testing is scarce.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.